Glenmark Pharmaceuticals recalls 325mg extended-release capsules due to manufacturing deviations. This may affect safety but no specific injury risk is described in the recall notice.
CGMP Deviations
Glenmark is recalling 325mg extended-release propafenone capsules (Rx only) because of manufacturing deviations. This recall does not specify a risk of injury or harm to users.
The recall mentions CGMP deviations, which are manufacturing quality control issues. However, the recall does not explain what these deviations mean for safety or how they could cause harm.
Prescription users of the 325mg extended-release propafenone capsules. Those with the specific lot number 17230767 are most at risk.
Check for the product name 'Propafenone Hydrochloride Extended-Release Capsules 325mg, 60-count bottle, Rx Only'. Look for lot number 17230767 or expiration date March 2025.
Identify the product by checking the lot number (17230767) and expiration date (March 2025) on the packaging.
The recall mentions CGMP deviations but does not describe any specific injury risk.
The recall does not provide specific action steps for users, only product identification details.
Check the lot number (17230767) and expiration date (March 2025) on the packaging.
We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.
Subject: Recall D-0316-2025 — Glenmark Glenmark Hello, I own a Glenmark that is covered by recall D-0316-2025 from Glenmark. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
